We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Eyes New Fees For Makers Of Over-The-Counter Drugs

Law360, New York (May 11, 2016, 8:25 PM EDT) -- The U.S. Food and Drug Administration on Tuesday said it is interested in collecting fees from manufacturers of over-the-counter drugs in order to address a “critically under-resourced” area of regulatory oversight....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.